IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v45y2022i11d10.1007_s40264-022-01230-y.html
   My bibliography  Save this article

Factors Influencing Preferences and Responses Towards Drug Safety Communications: A Conjoint Experiment Among Hospital-Based Healthcare Professionals in the Netherlands

Author

Listed:
  • Esther Vries

    (University of Groningen, University Medical Center Groningen
    Dutch Medicines Evaluation Board)

  • Elisabeth Bakker

    (University of Groningen, University Medical Center Groningen
    Dutch Medicines Evaluation Board)

  • Taco B. M. Monster

    (University of Groningen, University Medical Center Groningen
    Dutch Medicines Evaluation Board)

  • Petra Denig

    (University of Groningen, University Medical Center Groningen)

  • Peter G. M. Mol

    (University of Groningen, University Medical Center Groningen
    Dutch Medicines Evaluation Board)

Abstract

Introduction Healthcare professionals (HCPs) are informed about new drug safety issues through Direct Healthcare Professional Communications (DHPCs). The influence of DHPC content on the impact of the communication is unclear. Objectives The aim of this study was to assess the effect of content elements ‘frequency of the safety issue’, ‘seriousness of the safety issue’, ‘need to take action’, ‘life span of drug involved’ and ‘type of evidence supporting the safety issue’ on hospital-based HCPs’ preferences and responses towards DHPCs. Methods A survey study including a conjoint experiment was performed among hospital-based HCPs in the Netherlands. Hypothetical DHPCs varying on the five content elements were constructed. Each respondent received eight out of 16 hypothetical DHPCs and was asked about (1) importance to be informed (fixed-point scale), (2) preferred communication timing (multiple options) and (3) their stated actions (multiple options). Associations were tested using generalized linear mixed models. Results In total, 178 HCPs participated. DHPCs concerning more frequent or serious safety issues, or requiring action, were associated with a higher perceived importance to be informed and a preference for immediate communication. Periodic communication was preferred for DPHCs concerning less frequent or serious safety issues. The most commonly stated action was to discuss the DHPC with colleagues. Monitoring was common when this was recommended. High frequency and seriousness were associated with more prescribing-related actions. Conclusion Frequency and seriousness of the safety issue and the recommended action are likely to influence the impact of DHPCs. The timing of communication could be tailored depending on the content, where less urgent safety issues might be communicated periodically.

Suggested Citation

  • Esther Vries & Elisabeth Bakker & Taco B. M. Monster & Petra Denig & Peter G. M. Mol, 2022. "Factors Influencing Preferences and Responses Towards Drug Safety Communications: A Conjoint Experiment Among Hospital-Based Healthcare Professionals in the Netherlands," Drug Safety, Springer, vol. 45(11), pages 1369-1380, November.
    • Handle: RePEc:spr:drugsa:v:45:y:2022:i:11:d:10.1007_s40264-022-01230-y
    DOI: 10.1007/s40264-022-01230-y
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-022-01230-y
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40264-022-01230-y?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Sieta T. Vries & Maartje J. M. Sar & Amelia Cupelli & Ilaria Baldelli & Anna Marie Coleman & Dolores Montero & Ivana Šipić & Adriana Andrić & Annika Wennberg & Jane Ahlqvist-Rastad & Petra Denig & Pet, 2017. "Communication on Safety of Medicines in Europe: Current Practices and General Practitioners’ Awareness and Preferences," Drug Safety, Springer, vol. 40(8), pages 729-742, August.
    2. Sieta T. de Vries & Maartje J. M. van der Sar & Anna Marie Coleman & Yvette Escudero & Alfonso Rodríguez Pascual & Miguel-Ángel Maciá Martínez & Amelia Cupelli & Ilaria Baldelli & Ivana Šipić & Adrian, 2018. "Safety Communication Tools and Healthcare Professionals’ Awareness of Specific Drug Safety Issues in Europe: A Survey Study," Drug Safety, Springer, vol. 41(7), pages 713-724, July.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Anna Radecka & Louise Loughlin & Mick Foy & Margarida Viana de Ferraz Guimaraes & Viola Macolic Sarinic & Marina Dimov Giusti & Marina Lesicar & Sabine Straus & Dolores Montero & Julia Pallos & Jelena, 2018. "Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint Action," Drug Safety, Springer, vol. 41(12), pages 1285-1302, December.
    2. Esther Vries & Elisabeth Bakker & Remy D. C. Francisca & Stijn Croonen & Petra Denig & Peter G. M. Mol, 2022. "Handling of New Drug Safety Information in the Dutch Hospital Setting: A Mixed Methods Approach," Drug Safety, Springer, vol. 45(4), pages 369-378, April.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:45:y:2022:i:11:d:10.1007_s40264-022-01230-y. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.